Eyepoint Pharmaceuticals Inc (EYPT) Insider Trading
- $120,813,690.84
- $50,777,804.13
- Aug. 20, 2024
- Paul Ashton
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 20, 2024 | Director | 2,567 | $7.79 | Buy | $19,996.93 | |
July 12, 2024 | Director | 11,625 | $10.06 | Sell | $116,947.50 | |
May 14, 2024 | Director | 11,625 | $12.65 | Sell | $147,056.25 | |
May 6, 2024 | Major Shareholder | 850,000 | $11.86 | Buy | $10,081,000.00 | |
April 18, 2024 | Major Shareholder | 581,765 | $18.03 | Buy | $10,489,222.95 | |
Feb. 2, 2024 | SVP | 209 | $28.49 | Sell | $5,954.41 | |
Jan. 26, 2024 | Insider | 49,325 | $25.66 | Sell | $1,265,679.50 | |
Jan. 25, 2024 | SVP | 600 | $25.00 | Sell | $15,000.00 | |
Jan. 23, 2024 | Insider | 5,135 | $25.00 | Sell | $128,375.00 | |
Jan. 23, 2024 | SVP | 900 | $25.00 | Sell | $22,500.00 | |
Jan. 11, 2024 | Major Shareholder | 750,000 | $19.75 | Buy | $14,812,500.00 | |
Jan. 11, 2024 | Director | 1,910,500 | $19.45 | Sell | $37,159,225.00 | |
Jan. 9, 2024 | Major Shareholder | 105,000 | $21.32 | Buy | $2,238,600.00 | |
Jan. 8, 2024 | Insider | 22,913 | $21.13 | Sell | $484,151.69 | |
Dec. 13, 2023 | Insider | 1,458 | $20.00 | Sell | $29,160.00 | |
Dec. 8, 2023 | Major Shareholder | 588,235 | $17.00 | Buy | $9,999,995.00 | |
Dec. 6, 2023 | Director | 266,242 | $18.41 | Sell | $4,901,515.22 | |
Dec. 4, 2023 | Major Shareholder | 1,919,057 | $21.82 | Buy | $41,873,823.74 | |
Dec. 4, 2023 | Insider | 45,000 | $22.00 | Sell | $990,000.00 | |
Sept. 1, 2023 | Major Shareholder | 20,000 | $9.90 | Sell | $198,000.00 | |
Aug. 30, 2023 | Major Shareholder | 60,976 | $10.92 | Sell | $665,857.92 | |
Aug. 28, 2023 | Major Shareholder | 60,858 | $11.71 | Sell | $712,647.18 | |
Aug. 24, 2023 | Major Shareholder | 139,280 | $14.62 | Sell | $2,036,273.60 | |
Aug. 22, 2023 | Major Shareholder | 46,778 | $14.62 | Sell | $683,894.36 | |
May 30, 2023 | Director | 1 | $6.00 | Sell | $6.00 | |
Sept. 4, 2020 | CFO | 10,000 | $0.48 | Buy | $4,800.00 | |
Aug. 24, 2020 | CFO | 10,000 | $0.61 | Buy | $6,100.00 | |
March 12, 2020 | CFO | 10,000 | $0.96 | Buy | $9,600.00 | |
March 10, 2020 | CEO | 98,000 | $1.06 | Buy | $103,880.00 | |
Nov. 15, 2019 | CFO | 10,000 | $1.43 | Buy | $14,300.00 | |
May 13, 2019 | Director | 40,000 | $1.74 | Buy | $69,600.00 | |
April 1, 2019 | Director | 5,000 | $1.89 | Buy | $9,450.00 | |
March 29, 2019 | Director | 17,000 | $1.75 | Buy | $29,750.00 | |
March 29, 2019 | CEO | 28,500 | $1.76 | Buy | $50,160.00 | |
June 25, 2018 | Major Shareholder | 16,864,066 | $1.27 | Buy | $21,417,363.82 | |
March 28, 2018 | Major Shareholder | 8,606,324 | $1.10 | Buy | $9,466,956.40 | |
June 14, 2017 | Insider | 56,700 | $1.76 | Buy | $99,792.00 | |
Jan. 4, 2016 | VP | 5,000 | $4.70 | Sell | $23,500.00 | |
Dec. 22, 2015 | VP | 33,950 | $5.39 | Sell | $182,990.50 | |
Dec. 22, 2015 | CEO | 120,000 | $5.39 | Sell | $646,800.00 | |
Oct. 1, 2014 | CEO | 10,000 | $4.27 | Sell | $42,700.00 | |
Sept. 2, 2014 | CEO | 10,000 | $4.78 | Sell | $47,800.00 | |
Aug. 1, 2014 | CEO | 10,000 | $4.37 | Sell | $43,700.00 | |
July 1, 2014 | CEO | 10,000 | $4.32 | Sell | $43,200.00 | |
June 19, 2014 | CEO | 7,000 | $4.00 | Sell | $28,000.00 | |
June 17, 2014 | CEO | 7,700 | $4.00 | Sell | $30,800.00 | |
June 17, 2014 | VP | 7,900 | $4.00 | Sell | $31,600.00 | |
June 13, 2014 | CEO | 11,800 | $4.02 | Sell | $47,436.00 | |
June 13, 2014 | VP | 11,700 | $4.02 | Sell | $47,034.00 | |
Oct. 1, 2012 | Director | 10,000 | $1.68 | Buy | $16,800.00 |
Insiders are both buying and selling Eyepoint Pharmaceuticals Inc stock.
The insider traders at Eyepoint Pharmaceuticals Inc are: Paul Ashton, Ew Healthcare Partners, L.P., Cormorant Asset Management, Lp, George Elston, Dario A Paggiarino, Ye Liu, David Scott Jones, Nancy Lurker, Leonard S. Ross, David R Guyer, Lori Freedman, Paul Hopper, Wendy F Dicicco, John B Landis, Jay S Duker, Michael Craig Pine, and Douglas Evan Godshall
The most active insider trader at Eyepoint Pharmaceuticals Inc is Paul Ashton with 8 trades.
Ye Liu has sold the most Eyepoint Pharmaceuticals Inc stock with a total value of $79,219,971.22.
Cormorant Asset Management, Lp has bought the most Eyepoint Pharmaceuticals Inc stock with a total value of $99,576,141.69.
The most recent insider trade for Eyepoint Pharmaceuticals Inc was on Aug. 20, 2024.
The single biggest insider buy for Eyepoint Pharmaceuticals Inc was from Cormorant Asset Management, Lp with a total value of $41,873,823.74 on Dec. 4, 2023.
The single biggest insider sell for Eyepoint Pharmaceuticals Inc was from Ye Liu with a total value of $37,159,225.00 on Jan. 11, 2024.